Clinical trial
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
NCT02468778 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2015
- Completion date
- May 17, 2021
- Enrollment
- 54 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.